AESOP Technology Wins Coveted Place in Mayo Clinic Platform Accelerate Program

AESOP Technology Wins Coveted Place in Mayo Clinic Platform Accelerate Program

August 23, 2022:- AESOP Technology declared that they had been accepted into Mayo Clinic Platform_Accelerate, a 20-week program that supports early-stage health tech AI startups getting market-ready.

Participants are chosen through a competitive screening process where a discussion of Mayo Clinic leaders reviews them from the clinical and operational viewpoint, led by John Halamka, MD., President of Mayo Clinic Platform.

“It’s an amazing opportunity for a medical AI startup like us. Data is the power from which everything grows into power, and this program delivers de-identified patient datasets and tools to help us validate our resolutions,” states Jeremiah Scholl, the CPO of AESOP Technology. “This practical knowledge will help us go even further in designing better products. The fact that we get to be mentored by Mayo Clinic’s respected experts is inspiring.”

‘AESOP,’ which stands for ‘AI-Enhanced Safety of Prescription,’ is working to make physician data entry more accessible, faster, and less error-prone using machine learning on 3.2 billion data sets. The company has developed products capable of this. RxPrime detects wrong drug errors by checking if medications match patients’ diagnoses, age, and gender.

Errors can occur at any stage of the medication-use process, but more than 50% of them occur during the prescribing phase. RxPrime can detect potential and unexplained errors in prescriptions and provide optimal recommendations, even for the look-alike-sound-alike medication errors. It offers just-in-time decision support without interfering unnecessarily with the clinical consultation process.

The other is AESOP Technology’s latest clinical documentation improvement tool, DxPrime, making it easier for doctors to input correct diagnoses into electronic health record systems. This task can be challenging as there are 68,000 different diagnosis codes under the International Classification of Diseases (ICD). The ICD codes supported insurance and billing rather than clinical medicine.

“Medical professionals are more overwhelmed with their workload after the pandemic, and how AI can support them gains more significance,” says Jim Long, AESOP Technology’s CEO. “AI is revolutionizing the healthcare industry in a variety of ways, like any other industry. Healthcare has unique challenges, and this program will allow us be more grounded.”

As a participant of the Mayo Clinic Platform_Accelerate, AESOP Technology is pleased to expose itself to real-world applications, supporting future growth in this rapidly progressing field. As part of the program, Mayo Clinic will take an equity role in the startup.